Cambridge, MA, United States of America

Sanjay D'souza

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Crispr Therapeutics Ag, Vertex Pharmaceuticals, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjay D'souza. Retrieved from https://idiyas.com/inventor/sanjay-d-souza-rtyfgk7f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Sanjay D'souza in Hemoglobinopathies Treatment

Introduction

Sanjay D'souza is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of medical science, particularly in the treatment of hemoglobinopathies. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Sanjay D'souza holds a patent titled "Compositions and Methods for Editing Beta-Globin for Treatment of Hemoglobinopathies." This patent represents a breakthrough in the approach to treating disorders related to hemoglobin, showcasing his expertise and dedication to improving patient outcomes. He has 1 patent to his name.

Career Highlights

Sanjay is currently employed at Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Vertex allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical science.

Collaborations

Throughout his career, Sanjay has worked alongside notable colleagues such as Jason West and Brenda K Eustace. These collaborations have fostered a dynamic environment for innovation and research, leading to advancements in their shared field of expertise.

Conclusion

Sanjay D'souza's work exemplifies the impact of innovation in healthcare, particularly through his patent addressing hemoglobinopathies. His contributions at Vertex Pharmaceuticals, Inc. and collaborations with esteemed colleagues highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…